Zhiai Xu

43PUBLICATIONS
46CO-AUTHORS
Medical devicesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Neural engineeringGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 31, 2026
Engineering Polymeric Nano-PROTAC for Targeted Protein Degradation and Cancer Therapy.

|Jul 17, 2026
Molecular Engineering of Stimuli-Activatable Protein Degraders for Precise Cancer Therapy.

|Jun 18, 2026
POLY-Senolytic nanoplatform for tumor-specific eradication of senescent tumor cells and mitigation of radiotherapy-induced immune resistance of cancer.

|Jun 04, 2026
Glycoengineered Host-Guest Nanoparticles Potentiate Alzheimer's Disease Therapy via Lesion-Specific Modulation of Tau Pathology.

|Apr 03, 2026
Coassembled Prodrug Nanoparticles Mitigating the Acquired Resistance to Protein Degradation Therapy.

Jing Gao, Shumin Lei, Yiying Wang

|Feb 02, 2026
Dual-Responsive Bionic Transformable Silica-Based Nanoparticles Promoting Macrophage M1 Polarization for Ameliorating Glioblastoma Immunosuppressive Microenvironment.

Hanxue Meng, Mengzhen Wang, Yinuo Shen

Pageof 8

Frequent Collaborators

19 joint publications

Haijun Yu

13 joint publications

Wen Zhang

5 joint publications

Chunyong Ding

5 joint publications

Yang Tian